Prostate cancer and osteoporosis.

about

Dual Effect of Chrysanthemum indicum Extract to Stimulate Osteoblast Differentiation and Inhibit Osteoclast Formation and Resorption In Vitro Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period.

P2860

Q34495848-AD5187EA-208F-4DB8-AA58-0C9A682548B9 Q37452317-41ED8041-A281-4AAE-A63D-24746EF2D2DF

P2860

Prostate cancer and osteoporosis.

Item

http://www.wikidata.org/entity/Q45760007

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Prostate cancer and osteoporosis.

@en

Prostate cancer and osteoporosis.

@nl

type

Item

label

Prostate cancer and osteoporosis.

@en

Prostate cancer and osteoporosis.

@nl

prefLabel

Prostate cancer and osteoporosis.

@en

Prostate cancer and osteoporosis.

@nl

P1476

Prostate cancer and osteoporosis

@en

P2093

Harish K Datta

http://www.w3.org/2001/XMLSchema#string

Julie Walker

http://www.w3.org/2001/XMLSchema#string

Stephen P Tuck

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple newly identified loci associated with prostate cancer susceptibility

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

Gleason grading and prognostic factors in carcinoma of the prostate

Metastasis to bone: causes, consequences and therapeutic opportunities

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

Cancer statistics, 2006

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Molecular biology of bone metastasis.

A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy.

P2888

s11914-012-0131-2

P304

11-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-012-0131-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

B C Hanusch

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047237247

http://www.w3.org/2001/XMLSchema#string

P698

23355097

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Prostate cancer and osteoporosis.

about

P2860

P2860

Prostate cancer and osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921